Hypolipidemic properties of the extracts of Belamcanda chinensis leaves (BCLE) in KK-Ay mice

Authors

  • Ying Guo BIT&GS Technologies Co. Ltd. https://orcid.org/0000-0003-1635-8931
  • Rongji Dai Institute of Space Biology and Medical Engineering, School of Life Science, Beijing Institute of Technology, Beijing, China
  • Yulin Deng Institute of Space Biology and Medical Engineering, School of Life Science, Beijing Institute of Technology, Beijing, China,
  • Lili Sun BIT&GS Technologies Co. Ltd., Beijing, China
  • Shiying Meng BIT&GS Technologies Co. Ltd., Beijing, China
  • Nian Xin BIT&GS Technologies Co. Ltd., Beijing, China

DOI:

https://doi.org/10.1590/s2175-97902020000118957%20

Keywords:

Belamcanda chinensis leaves, Type 2 diabetes, Hypolipidemic effect, SOD, MDA

Abstract

The extract of Belamcanda chinensis leaves (BCLE) is a traditional Chinese herbal medicine for the treatment of diabetes-related hyperlipidemia in Hainan province, South China. In this study, the lipid-decreasing effects of BCLE on obese diabetes were investigated on KK-Ay mice. The component F2 ameliorated lipid disorder, as indicated by decreased levels of body weight, liver index, levels of TC, TG and LDL-c in the serum and liver. The enhancement effect of F2 on liver SOD and the inhibitory effect of F2 on MDA demonstrated that F2 exhibited significant antioxidant activity on liver injury. F2 also prevented vacuolar degeneration and reduced pathological tissue injury in liver. In addition, the component F1 decreased the levels of TG, LDL-c and MDA in the liver. These findings suggest that F2 may have therapeutic potential in the prevention and therapy of hyperlipemia and liver disease associated with obesity-related diabetes.

Downloads

Download data is not yet available.

References

Benkhalti F, Prost J, Paz E, Jimenez F, Modafar C, Boustani E. Effects of feeding virgin olive oil or their polyphenols on lipid of rat liver. Nutr Res. 2002;22(9):1067-1075.

Chen Y, Wu CM, Dai RJ, Li L, Yu YH, Li Y, et al. Combination of HPLC chromatogram and hypoglycemic effect identifies isoflavones as the principal active fraction of Belamcanda chinensis leaf extract in diabetes treatment. J Chromatogr B. 2011;879(5-6):371.

Dai QH, Wang ZD. Investigation on the status of diabetes in China. Guide of China Medicine. 2011; 13.

Herberg L. Coleman DL Laboratory animals exhibiting obesity and diabetes syndromes. Brookings Institution. 1977;26(1):59-99.

Jacob EF. Obesity and gestational diabetes mellitus pathways for programming in mouse, monkey, and man-where do we go next? The 2014 Norbert Freinkel Award Lecture. Diabetes Care. 2015;38(8):1402-1411.

Li W, Zhang M, Gu J. Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 Diabetes mice induced by High-Fat Diet combining with Streptozotocin via suppression of hepatic gluconeogenesis. Fitoterapia. 2012;83(1):192-198.

Miu YD, Ouyang Z, Yuan B. Study on reducing blood lipid effect of extracts from Gegen, Hawthorn and Shouwu prepared. Res Pract PRC Med. 2008;22(3)27-29.

Perry RJ, Samuel VT, Petersen KF. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510(7503):84-91.

Ou Y, Lin L, Yang XG, Pan Q, Cheng X. Antidiabetic potential of phycocyanin: Effects on KK-Ay mice. Pharm Biol. 2013;51(5):539-544.

Papaioannou VE, Gardner RL. Effects of diapause on lethal Yellow (Ay/Ay) mouse embryos. J Exp Zool A Ecol Genet Physiol. 1992;263(3):309-315.

Qia XY, Chen WJ, Zhang LQ, Xie BJ. Mogrosides extract from Siraitia grosvenori scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice. Nutr Res Pract. 2008;28(4):278-84.

Rosenbaum D, Dallongeville J, Sabouret P, Bruckert E. Discontinuation of statin therapy due to muscular side effects: A survey in real life. Nutr Metab Cardiovas. 2013;23(9): 871-875.

Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview. Indian J Med Res. 2012;136:451-472.

Wu CM, Chen Y, Li Y, Lao X, Sheng L, Dai R, Meng W, Deng Y. Hypoglycemic effect of Belamcanda chinensis leaf extract in normal and STZ-induced diabetic rats and its potential active faction. Phytomedicine. 2011;18(4):292-297.

Zhang L, Wei KH, Xu JP, Yang D, Zhang C, Wang Z, Li M. Belamcanda chinensis (L.) DC-An ethnopharmacological, phytochemical and pharmacological review. J Ethnopharmacol. 2016;186:1-13.

Downloads

Published

2022-04-22

Issue

Section

Original Article

How to Cite

Hypolipidemic properties of the extracts of Belamcanda chinensis leaves (BCLE) in KK-Ay mice. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902020000118957